Methylprednisolone vs Nivolumab
Methylprednisolone vs Nivolumab: Overview
This comparison examines the pharmacological differences between Methylprednisolone and Nivolumab.
Mechanism of Action
Methylprednisolone: Intermediate-acting synthetic glucocorticoid.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Methylprednisolone — 18-36 hours; Nivolumab — 27 days.
Chemical Properties
Molecular Formula: Methylprednisolone — C22H30O5.
Molecular Weight: Methylprednisolone — 374.4710 g/mol.
Type: Methylprednisolone — Small molecule; Nivolumab — Antibody.